Systematic profiling of antigen bias in humoral response against SARS-CoV-2SARS-CoV-2에 대한 체액 반응의 항원 편향에 대한 체계적인 프로파일링Article Published on 2022-04-152022-09-11 Journal: Virus research [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] adverse events antibodies Antigen Antigen bias Asymptomatic collected epitope Epitopes evaluate humoral humoral immune response IgG and IgM IgM responses immune system Microarray Patient patients peptide peptides promote Protein Proteome microarray RBD recovered patient response S-specific antibody SARS-CoV-2 SARS-CoV-2 vaccines sera significantly symptomatic the SARS-CoV-2 [DOI] 10.1016/j.virusres.2022.198711 PMC 바로가기 [Article Type] Article
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19코비드-19를 가진 고위험, 입원하지 않은 성인을 위한 경구 NirmatrelvirClinical Trial Published on 2022-04-142022-09-11 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 신약개발, 임상, 진단, 치료제, [키워드] 1:1 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus adjusted Administered adverse event adverse events Analysis assigned conducted Controlled trial coronavirus coronavirus disease Coronavirus disease 2019 death deaths diarrhea double-blind drug dysgeusia enhancer evaluated Final final analysis high risk Hospitalization in vitro incidence inhibitor initiated interim analysis log M pro mean difference milliliter modified intention-to treat modified intention-to-treat Nirmatrelvir occurred onset of symptoms oral Patient patients patients treated Pfizer pharmacokinetic Placebo placebo group progression protease randomization randomized, controlled trial receive Relative risk risk risk reduction Ritonavir Serious Adverse Events severe acute respiratory syndrome Coronavirus severe coronavirus disease severe COVID-19 symptom onset symptomatic symptomatic COVID-19 the placebo group Treatment treatment period two group two groups Viral load [DOI] 10.1056/NEJMoa2118542 PMC 바로가기 [Article Type] Clinical Trial
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance studySARS-CoV-2 감염이 확인된 백신 접종을 하지 않은 무증상 및 증상이 있는 가구 구성원으로부터 SARS-CoV-2의 가구 전파: 항체 감시 연구Article Published on 2022-04-122022-09-11 Journal: CMAJ open [Category] COVID19(2023년), SARS, 진단, 치료법, [키워드] 95% CI 95% confidence interval Adults age Antibody testing Asymptomatic attack rate bedroom Chain Reaction Child children Clustering conducted contribute COVID-19 COVID-19 pandemic defined Descriptive statistics eligible eligible participant emergency department enrolled enrolment enzyme enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays evaluate Health policy household household contact household contacts household transmission Households IgA IgM and IgG individual media multivariable logistic regression nucleocapsid protein number of household Odds ratio outcome participant Participation Patient performed polymerase chain polymerase chain reaction positive positive result predictor Primary outcome proportion public health required reverse transcription robust SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antibody testing SARS-CoV-2 transmission secondary attack rate Spread standard error study participation study period subgroups symptomatic symptomatic and asymptomatic tested Transmission transmission of SARS-CoV-2 transmitted were used [DOI] 10.9778/cmajo.20220026 PMC 바로가기 [Article Type] Article
IoT-Enabled Framework for Early Detection and Prediction of COVID-19 Suspects by Leveraging Machine Learning in Cloud클라우드에서 기계 학습을 활용하여 COVID-19 의심의 조기 탐지 및 예측을 위한 IoT 지원 프레임워크Article Published on 2022-04-122022-09-11 Journal: Journal of Healthcare Engineering [Category] 치료기술, [키워드] Accuracy advancement Algorithm Algorithms calculated cloud collected conducted COVID-19 COVID-19 virus Data collection dataset Decision tree detect detection diagnostic early stages effective Efficiency experiment FIVE framework globe health parameter health parameters Healthcare system Healthcare systems Internet Logistic regression machine learning naïve Naïve Bayes outbreak Performance metrics Precision prediction reactive real time recall root searched selected shown Support SVM symptomatic Symptoms the disease virus [DOI] 10.1155/2022/7713939 PMC 바로가기 [Article Type] Article
A pre-symptomatic incubation model for precision strategies of screening, quarantine, and isolation based on imported COVID-19 cases in Taiwan대만의 수입 COVID-19 사례를 기반으로 한 선별, 검역 및 격리의 정밀 전략을 위한 증상 전 인큐베이션 모델Article Published on 2022-04-112022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 임상, 치료기술, [키워드] Algorithm applied Bayesian border control caused Chain Reaction Computer simulation COVID COVID-19 case COVID-19 cases credible interval declined disease Disease progression distribution Epidemic experiment facilitated Incubation period Isolation polymerase chain polymerase chain reaction pre-symptomatic Precision quarantine required risk RT-PCR stochastic process symptomatic Taiwan the median Vaccine viral variant [DOI] 10.1038/s41598-022-09863-w PMC 바로가기 [Article Type] Article
Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients25명의 B-세포 결핍 환자에서 회복기 혈장으로 코로나바이러스 질병 2019 치료의 효과Article Published on 2022-04-092022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 진단, [키워드] 19 2 antibody B B-cell-depleted patient Cell cell depletion convalescent convalescent plasma coronavirus disease CoV COVID diagnosed Effect immunodeficiency median neutralizing antibody titers remained SARS symptomatic therapeutic effect therapy treated [DOI] 10.1093/cid/ciab647 PMC 바로가기 [Article Type] Article
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 감염 및 B.1.1.7 항체 및 백신 접종 상태에 따른 의료 종사자의 변이 감염 발생률에 대한 관찰 코호트 연구Observational Study Published on 2022-04-092022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, 임상, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted age anti-spike antibodies anti-spike antibody antibody B.1.1.7 B.1.1.7 variant BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 Chain Reaction changes in confidence interval coronavirus coronavirus 2 detectable dose doses evade Evidence evidence of HCW HCWs healthcare healthcare worker Healthcare workers Immunity incidence incidence rate Infection investigated longitudinal cohort study natural natural immunity natural infection no evidence of Oxford-AstraZeneca pandemic PCR-positive Pfizer-BioNTech Poisson regression polymerase chain polymerase chain reaction provided rate ratio reduced respiratory resulting robust S-gene SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants Sequencing seronegative seropositive Seropositivity severe acute respiratory syndrome Coronavirus Sex Single-dose status symptomatic symptomatic and asymptomatic symptomatic infection United Kingdom vaccination Vaccine vaccine dose Vaccine-induced immunity whole genome Whole genome sequencing without symptom worker [DOI] 10.1093/cid/ciab608 PMC 바로가기 [Article Type] Observational Study
CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 testCHARM: qPCR SARS-CoV-2 테스트 양성 후 무증상 및 증상 감염에 대한 항원 특이적 인터페론-감마 및 IL2 반응의 해병을 위한 COVID-19 건강 조치 대응Article Published on 2022-04-072022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 진단, 치료법, [키워드] Action All participants Asymptomatic Asymptomatic cases Cell mediated immunity class correlated COVID-19 COVID-19 symptoms COVID-19 vaccine COVID-19 vaccines dropped enrolled Enrollment epitope Epitopes Follow-up frequencies Frequency IFN-γ IFN-γ response IFN-γ responses IL2 immune response include Infection membrane N and M N and S proteins N protein nucleocapsid occurred participant Participants peaked peptide peptide pool peptides positive Post-infection predicted Protein Proteins qPCR qPCR test Responder response responses S proteins S, N and M proteins SARS-CoV-2 SARS-CoV-2 antigens SARS-COV-2 infection SARS-CoV-2 test significantly Study participants subjects Support symptomatic symptomatic and asymptomatic symptomatic infection symptomatic participants T cell T cell response T cell responses tested the N protein These data were measured with COVID-19 [DOI] 10.1371/journal.pone.0266691 PMC 바로가기 [Article Type] Article
How optimal allocation of limited testing capacity changes epidemic dynamics제한된 테스트 용량의 최적 할당이 전염병 역학을 어떻게 변화시키는지Article Published on 2022-04-072022-09-11 Journal: Journal of theoretical biology [Category] COVID19(2023년), SARS, 치료기술, [키워드] Asymptomatic asymptomatic individual Asymptomatic individuals change clinical clinical testing Concentration Contact COVID-19 Critical detect Epidemic Epidemiology General population Guidance highlight implementation Increases individual individuals infection risk Insufficient Intervention lockdowns Optimal control pandemic parameter patients pre-symptomatic quarantine reduction resource SARS-CoV-2 SEIR SEIR model social distancing symptomatic tested [DOI] 10.1016/j.jtbi.2022.111017 PMC 바로가기 [Article Type] Article
Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort Research Published on 2022-04-052022-10-05 Journal: Nature Communications [Category] COVID19(2023년), SARS, 치료법, [키워드] acute respiratory syndrome analysed Cohort coronavirus COVID COVID-19 disease COVID-19 symptom disease Dyspnoea France Infection Long paraesthesia Patient Prevalence prevalent reported symptom response Symptom symptom onset symptomatic Symptoms validated self-reported questionnaire was determined [DOI] 10.1038/s41467-022-29513-z [Article Type] Research